Media Statements

  • February 17, 2017
    PARSIPPANY, N.J.  – Feb. 17, 2017 - We at Zoetis are pleased that the European Medicines Agency, Committee for Veterinary Products for Medicinal Use, adopted a positive opinion for Cytopoint™ at their February meeting.Upon full approval, Cytopoint would become the first monoclonal antibody licensed for veterinary use in the European Union. It is indicated for the treatment of clinical manifestations of atopic dermatitis in dogs.more...
  • June 2, 2015
    Today the U.S. Food and Drug Administration published the finalized Veterinary Feed Directive (VFD). This regulation mandates the rules and responsibilities of licensed veterinarians in prescribing and administering medically important antibiotics in feed.We are reviewing the Veterinary Feed Directive in detail. We support the intent of the Veterinary Feed Directive (VFD) regulation to guide veterinarians and farmers as they manage the health and welfare of animals.more...
  • December 11, 2013
    Today the U.S. Food and Drug Administration finalized Guidance #213 establishing the procedures for voluntarily phasing out growth promotion indications for medically important antibiotics in alignment with Guidance #209 and published proposed changes to the Veterinary Feed Directive (VFD) regulation.The VFD regulation mandates the rules and responsibilities of licensed veterinarians in prescribing and administering medically important antibiotics in feed.more...
  • May 20, 2013
    MADISON, NJ - May 20, 2013 –Zoetis Inc. (NYSE: ZTS) acknowledges that the European Commission started a procedure under Article 45 of Regulation (EC) No. 726/2004 regarding the EU marketing authorization for Suvaxyn PCV, a centrally-authorized vaccine against Porcine Circovirus 2 in swine. As part of this procedure, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Veterinary Use (CVMP) discussed the issue during its latest monthly meeting (14-16 May 2013) .more...